$153.49
4.11 (-2.61%)
Last updated: Jul 15, 2026 04:26
Fundamentals Overview
ICU Medical, Inc. is near the high of its 52-week range with premium valuation, trending downward today.
Valuation premium
Profitability
Risk (Beta)
0.76 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Analyst grade: B- · Sentiment improving (3 upgrades) · 3M vs S&P 500: +9.1% · 3M vs Healthcare sector: +11.7%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B-. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 2, Hold: 1, Market Perform: 1, Outperform: 7, Overweight: 17, Strong Buy: 2.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $-8.24; current price is $153.49. That’s a -105.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 83.41 |
| PEG (TTM) | 0.56 |
| P/B (TTM) | 1.8 |
| P/S (TTM) | 1.78 |
| P/FCF (TTM) | 47.72 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 2.3 |
| Quick Ratio (TTM) | 1.13 |
| Cash Ratio (TTM) | 0.56 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 2.15% |
| Gross margin (TTM) | 36.36% |
| Operating margin (TTM) | 3.72% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for ICUI.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Needham | upgrade | Hold | Buy | 2026-05-27 |
| Keybanc | maintain | Overweight | Overweight | 2026-04-27 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-04-17 |
| Keybanc | maintain | Overweight | Overweight | 2026-02-20 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-02-20 |
| Keybanc | maintain | Overweight | Overweight | 2025-11-07 |
| Piper Sandler | maintain | Overweight | Overweight | 2025-11-07 |
| Keybanc | maintain | Overweight | Overweight | 2025-10-21 |
| Piper Sandler | maintain | Overweight | Overweight | 2025-09-10 |
| Raymond James | maintain | Strong Buy | Strong Buy | 2025-08-08 |
| Raymond James | maintain | Strong Buy | Strong Buy | 2025-05-09 |
| Keybanc | maintain | Overweight | Overweight | 2025-04-21 |
| Needham | maintain | Hold | Hold | 2025-04-08 |
| Jefferies | upgrade | Hold | Buy | 2024-12-11 |
| Keybanc | maintain | Overweight | Overweight | 2024-11-13 |
| Keybanc | maintain | Overweight | Overweight | 2024-10-15 |
| Raymond James | maintain | Outperform | Outperform | 2024-09-12 |
| Keybanc | maintain | Overweight | Overweight | 2024-08-08 |
| Raymond James | maintain | Outperform | Outperform | 2024-08-08 |
| Raymond James | upgrade | Market Perform | Outperform | 2024-06-17 |
| Keybanc | maintain | Overweight | Overweight | 2024-02-28 |
| Keybanc | maintain | Overweight | Overweight | 2023-05-09 |
| Raymond James | downgrade | Outperform | Market Perform | 2022-11-08 |
| Raymond James | maintain | Outperform | Outperform | 2022-08-09 |
| Keybanc | maintain | Overweight | Overweight | 2022-08-09 |
| Raymond James | maintain | Outperform | Outperform | 2022-08-08 |
| Keybanc | maintain | Overweight | Overweight | 2022-08-03 |
| Keybanc | maintain | Overweight | Overweight | 2022-05-10 |
| Raymond James | maintain | Outperform | Outperform | 2022-05-10 |
| Raymond James | maintain | Outperform | Outperform | 2022-02-28 |